August 10, 2026 07:00 ET | Source: Curium BOSTON and LIEGE, Belgium, Aug. 10, 2026 (GLOBE NEWSWIRE) — Curium™ a leading global radiopharmaceutical company, announced that it has completed the acquisition of Abscint SA, a Belgian clinical-stage radiopharmaceutical company developing innovative diagnostic imaging agents for oncology. Through the transaction, Curium has acquired the global rights to develop,
August 06, 2026 09:00 ET | Source: Royal Philips August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home Amsterdam, Netherlands. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree
Investigators Present Data Supporting Disease-Modifying Potential of the Io Therapeutics RXR Agonist Compound IRX4204 in Parkinson’s Disease August 05, 2026 12:30 ET | Source: Io Therapeutics, Inc. SPRING, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas, announced today the presentation of new research demonstrating that IRX4204,
To mark World Breastfeeding Week, Medela announces the recipient of its research contribution and launches a month-long campaign highlighting evidence-based lactation care August 04, 2026 08:00 ET | Source: Medela Baar, Switzerland, Aug. 04, 2026 (GLOBE NEWSWIRE) — Baar, Switzerland, August 4, 2026 – To mark World Breastfeeding Week (WBW), observed globally from August 1–7, Medela, the brand trusted by
August 04, 2026 08:00 ET | Source: Cirrus Therapeutics, Inc. CAMBRIDGE, Mass. and SINGAPORE, Aug. 04, 2026 (GLOBE NEWSWIRE) — Cirrus Therapeutics, an ocular immunology biotech, today announced a collaboration with Singapore Eye Research Institute (SERI) and Duke-NUS Medical School (Duke-NUS). Cirrus also announced an expanded investor syndicate, including Cedars Sinai Intellectual Property Company, raising $14.7 million
August 03, 2026 07:31 ET | Source: Lantheus Holdings, Inc. BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) — Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), today announced
July 29, 2026 10:00 ET | Source: Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System. Utilizing cutting-edge accelerated computing and AI technology, the TESSA (Tracking Enabled Spatial Surgery Assistant)
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer July 28, 2026 17:37 ET | Source: Celloram Inc. Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients. CLEVELAND, July 28, 2026 (GLOBE NEWSWIRE) — In
July 28, 2026 16:12 ET | Source: Alamar Biosciences, Inc. Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging Highly sensitive multiplex measurement captures regulatory proteins, like checkpoint inhibitors, and low abundance targets that standard platforms routinely miss FREMONT, Calif., July 28, 2026
July 28, 2026 08:59 ET | Source: AGC Biologics, Inc. YOKOHAMA, Japan, July 28, 2026 (GLOBE NEWSWIRE) — Ahead of the official opening of AGC Biologics’ Yokohama site, an international biopharmaceutical company has already secured half of the facility’s mammalian manufacturing capacity with a multi-year commercial contract expected to reach hundreds of millions of dollars in total
July 27, 2026 14:52 ET | Source: Royal Philips July 27, 2026 Q2 2026 Group performance Roy Jakobs, CEO of Royal Philips:“We delivered another solid quarter with comparable sales growth of 4%, driven by all business segments, and strong disciplined execution within an uncertain macro environment. Customer demand for our innovations remains healthy, with certain large orders
As major medical societies call for mandatory adoption of Enhanced Radiation Protection Devices (ERPDs), the EggNest® Complete system emerges as the definitive solution to protect the entire clinical team July 22, 2026 15:26 ET | Source: Egg Medical, Inc. MINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) — Egg Medical, a global leader in radiation protection, announced its alignment with
Seasoned global business leader to drive the growth of Acentra Health’s India organization and accelerate the company’s transformation journey July 22, 2026 05:00 ET | Source: Acentra Health LLC MCLEAN, Va., July 22, 2026 (GLOBE NEWSWIRE) — Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the
July 21, 2026 19:10 ET | Source: Junshi Biosciences SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental application for toripalimab in combination with platinum-containing chemotherapy as perioperative treatment
July 21, 2026 07:02 ET | Source: Axiom Biosciences SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) — Axiom Biosciences, a clinical-stage biotechnology company whose lead regenerative therapy produced positive early results in newborns with severe brain injury, today announced its intention to pursue an initial public offering on the Main Board of The Stock Exchange of Hong Kong
